Profil
Tijana Tomić
Zvanje:
Istraživač saradnik
Direktni telefoni:
Lokal:
Naučna oblast:
1
Veće oblasti:
Orcid broj:
Organizaciona jedinica:
080
DIPLOME
ZVANJA
M faktor
Kategorija | Broj | Koeficijent | Ukupno |
---|---|---|---|
M11 | 0 | 14 | 0 |
M12 | 0 | 10 | 0 |
M13 | 0 | 7 | 0 |
M14 | 0 | 4 | 0 |
M15 | 0 | 3 | 0 |
M16 | 0 | 2 | 0 |
M17 | 0 | 3 | 0 |
M18 | 0 | 2 | 0 |
M21a | 0 | 10 | 0 |
M21 | 2 | 8 | 16 |
M22 | 0 | 5 | 0 |
M23 | 0 | 3 | 0 |
M24 | 0 | 2 | 0 |
M25 | 0 | 1.5 | 0 |
M26 | 0 | 1 | 0 |
M27 | 0 | 0.5 | 0 |
M28a | 0 | 3.5 | 0 |
M28b | 0 | 2.5 | 0 |
M29a | 0 | 1.5 | 0 |
M29b | 0 | 1.5 | 0 |
M29v | 0 | 1 | 0 |
M31 | 0 | 3.5 | 0 |
M32 | 0 | 1.5 | 0 |
M33 | 0 | 1 | 0 |
M34 | 6 | 0.5 | 3 |
M35 | 0 | 0.3 | 0 |
M36 | 0 | 1.5 | 0 |
M41 | 0 | 7 | 0 |
M42 | 0 | 5 | 0 |
M43 | 0 | 3 | 0 |
M44 | 0 | 2 | 0 |
M45 | 0 | 1.5 | 0 |
M46 | 0 | 1 | 0 |
M47 | 0 | 0.5 | 0 |
M48 | 0 | 2 | 0 |
M49 | 0 | 1 | 0 |
M51 | 0 | 2 | 0 |
M52 | 1 | 1.5 | 1.5 |
M53 | 0 | 1 | 0 |
M54 | 0 | 0.2 | 0 |
M55 | 0 | 1 | 0 |
M56 | 0 | 0.3 | 0 |
M57 | 0 | 0.2 | 0 |
M61 | 0 | 1.5 | 0 |
M62 | 0 | 1 | 0 |
M63 | 0 | 1 | 0 |
M64 | 0 | 0.2 | 0 |
M65 | 0 | 0 | 0 |
M66 | 0 | 1 | 0 |
M67 | 0 | 0 | 0 |
M68 | 0 | 0 | 0 |
M69 | 0 | 0 | 0 |
M71 | 0 | 6 | 0 |
M72 | 0 | 3 | 0 |
M81 | 0 | 0 | 0 |
M82 | 0 | 0 | 0 |
M83 | 0 | 0 | 0 |
M84 | 0 | 0 | 0 |
M85 | 0 | 0 | 0 |
M86 | 0 | 0 | 0 |
M87 | 0 | 0 | 0 |
M91 | 0 | 0 | 0 |
M92 | 0 | 0 | 0 |
M93 | 0 | 0 | 0 |
M94 | 0 | 0 | 0 |
M95 | 0 | 0 | 0 |
M96 | 0 | 0 | 0 |
M97 | 0 | 0 | 0 |
M98 | 0 | 0 | 0 |
M99 | 0 | 0 | 0 |
M101 | 0 | 0 | 0 |
M102 | 0 | 0 | 0 |
M103 | 0 | 0 | 0 |
M104 | 0 | 0 | 0 |
M105 | 0 | 0 | 0 |
M106 | 0 | 0 | 0 |
M107 | 0 | 0 | 0 |
M108 | 0 | 0 | 0 |
M109 | 0 | 0 | 0 |
M110 | 0 | 0 | 0 |
M111 | 0 | 0 | 0 |
M112 | 0 | 0 | 0 |
M121 | 0 | 3 | 0 |
M122 | 0 | 2 | 0 |
M123 | 0 | 1 | 0 |
M124 | 0 | 1 | 0 |
Ukupno M faktor:
20.5
NI radovi
# | Naziv, Datum, Grupa, Vrsta | Godina | Autori | Status | Akcija |
---|---|---|---|---|---|
1 |
Role of TP53 and PTEN tumor suppressor genes alterations in breast cancer response to therapy
THE FIFTH CONGRESS OF THE SERBIAN ASSOCIATION FOR CANCER RESEARCH - Translational potential of cancer research in Serbia , , 2021 M30 | M34 |
2021 | Milica Nedeljković, Tatjana Dramićanin, Mirjana Prvanović, Blagoje Murganić, Tijana Tomić, Neila Ademović, Zorka Milovanović, Nikola Tanić, Nasta Tanić |
Odobren
|
|
2 |
Role of claudins 3, 4 and 7 in triple negative breast cancer progression
6th Congress of SDIR: From Collaboration to Innovation in Cancer Research, Oncology Insights : official Journal of the Serbian Association for Cancer Research , , 2023 M30 | M34 |
2023 | Irena Jovanić, Milica Nedeljković, Nataša Medić-Milijić, Igor Spurnić, Zorka Milovanović, Tijana Tomić, Nasta Tanić, Nikola Tanić |
Odobren
|
|
3 |
Genomic instability as a prognostic marker in malignant brain cancer
6th Congress of SDIR: From Collaboration to Innovation in Cancer Research, Oncology Insights : official Journal of the Serbian Association for Cancer Research , , 2023 M30 | M34 |
2023 | Nejla Ademović, Tijana Tomić, Nasta Tanić, Marina Milić, Miodrag Rakić, Nikola Tanić |
Odobren
|
|
4 |
Prognostic and Clinical Significance of PD-L1, EGFR and Androgen Receptor (AR) Expression in Triple-Negative Breast Cancer (TNBC) Patients
Life , , 2024 M20 | M21 |
2024 | Nataša Medić-Milijić, Irena Jovanić, Milica Nedeljković, Ivan Marković, Igor Spurnić, Zorka Milovanović, Nejla Ademović, Tijana Tomić, Nasta Tanić, Nikola Tanić |
Odobren
|